| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.6M | — | +331.7% |
| R&D Expense | $19.8M | — | +139.9% |
| SG&A Expense | $6.9M | — | -18.6% |
| Operating Income | -$14.1M | — | -1.9% |
| Net Income | -$9.5M | — | +28.2% |
| EPS (Basic) | -$0.58 | — | -222.2% |
| EPS (Diluted) | -$0.58 | — | -222.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $150.3M | +9.3% | +68.8% |
| Current Assets | $154.2M | +6.3% | +65.5% |
| Total Assets | $163.5M | +5.7% | +57.6% |
| Current Liabilities | $43.0M | -23.7% | -9.8% |
| Total Liabilities | $90.9M | -23.8% | -2.2% |
| Stockholders' Equity | $72.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.3M | — | -177.1% |
| Capital Expenditures | $556K | — | +2427.3% |
| Investing Cash Flow | -$556K | — | -2427.3% |
| Financing Cash Flow | $35.7M | — | +639.0% |
| Free Cash Flow | -$22.9M | — | -179.1% |
| +578.0% |